Ambiguity In Patent Laws May Defer New Drug Launches
Indian Government has refused to grant product patent for Glivec, the cancer drug from Novartis AG, the ... should focus their research on this area. Product patent alone is not sufficient but data individuality is more important. JYT...Ayurveda Firm's Name Change Irks Experts
... was high time the Kerala government took steps to patent its ayurveda system. "I have had several complaints from foreigners that ayurveda is being misused here. Moreover, countries like Sri Lanka are also promoting ayurveda in a big way and it is here that the government should step in," said Najeeb. ...Thailand Backs Off Threat to Break Drug Patents
Thailand has delayed breaking the patent of an AIDS drug and a heart medicine, and entered ... Last month the government threatened to break the patent on both Kaletra and Plavix, a heart medicine produced by Sanofi-Aventis and Bristol-Meyers Squibb. I...Merck Announces Plans for Licensing Atripla Widely in Developing World
... commercialisation will remain in the hands of the patent holders. This is likely to prevent any significant competitive pressure on the price of the product, since once licenses are granted, competition from generic versions of this fixed dose combination will be impossible without the granting of compulso...Drug Companies Hit Out at Thai Generic Drug Scheme
..., drug companies maintain that the plan undermines patent law and discourages foreign investment. "We were disappointed by the announcement," Bangkok CEO of US drug firm, Merck Sharp and Dome, Christian Sellars, told Radio Australia's Karon Snowdon. "We have been working with the Thai government to see ......age of 5. Sanofi-Aventis has also decided not to patent this drug which would enable the other companies to manufacture this drug at a cheaper rate for developing nations. The cheaper price of this drug would dissuade the counterfeiters from making them as there is no profit for them in this endeavor. ...India, China Trying to Fight Disease With Nanotechnology
...hnology Initiative. The number of nanotechnology patent applications from China ranks third, behind the US and Japan. In Brazil, the projected budget for nanoscience during 2004-2007 was about $25 million. The South African Nanotechnology Initiative is a national network of academic researchers involved...FDA Decision Encourages Lamictal Generics
...ing was in response to a citizen's petition from a patent attorney that was filed in June 1995. However, ...he drug, the respective company could still face a patent suit from Glaxo as the patent in the US is not due to run out until 2009. Lamictal already faces gen...New Study: Pine Bark Significantly Reduces Endometriosis
...etriosis by 33 percent. Pycnogenol which holds a patent for reducing PMS/menstrual pain and discomfort, was chosen for this study because other endometriosis treatments can have unwanted side effects. "The cause of endometriosis is unknown and treatment to fully cure endometriosis has yet to be developed,...No Carrier Necessary: This Drug Delivers Itself
...nventional, surfactant-based delivery systems. A patent has been filed on this work. "In this case, the drug itself acts as its own carrier," said Haridas Pudavar, Ph.D., UB research assistant professor of chemistry and a co-author. The nanocrystals present a major advantage over methods of delivery i...India Fast Become Prime Location for Clinical Trials, but Vigilance Called for
...e the clinical trial boom. Apart from changes in patent laws, which will protect data confidentiality, initial or phase-1 trials are also permitted. A Framework for Good Clinical Practices has also been announced. In the budget for 2007-08, the service tax on clinical trials was done away with. How...Sanofi-Aventis Allows Thais To Make Plavix
...ailand government when it decided to supersede the patent on Efavirenz, a drug for HIV from Merck & Co. Late...atented medicine without the approval of a foreign patent owner. But according to Thailand government essential medicines are too expensive for the country’s ...FDA Cites Challenges of Generic Biotech
...ons of traditional drugs after the originals loose patent protection. Waxman's new legislation would give generic drug makers access to an estimated $12 billion worth of biotech patents that have already expired. Unlike traditional chemical-based pharmaceuticals, biotech pharmaceuticals are made from livi...Constipation Drug Linked to Heart Attack Pulled Out
... Novartis that has challenged the rejection of its patent application for a cancer drug by Indian authoritie...awaited as this is the first test case for India’s patent laws under the WTO regime.) Earlier the FDA had approved Zelnorm, also called tegaserod maleate, f...Indian Court Refers Novartis Plea for Patent on Anti-cancer Drug to a Separate Board
... For it cannot hope for any early decision on the patent plea. The Appellate Board’s ruling too can be chal...ice is situated in Chennai. It wanted rejection of patent application set aside. That appeal goes before the appellate board set up by the government of India......, Novartis, has brought against India, demanding a patent for one of its products (Gleevac, a leukemia drug)...provements in their products and then insisting on patent renewal. India has been saying the products are not new really and makes its own versions at rela...Patent Problems in US – Over Stem Cell Researc
...e Novartis seems to be receiving in its efforts to patent its anti-cancer drug Glivec, comes the news that the US Patent// and Trademark Office has made a preliminary decision to revoke three fundamental patents on human embryonic stem cells granted in the last few years. Patent examiners rejected all the ...Law Emerging in US for Generic Versions of Biotech Medicine
...booming generic drug industry while protecting the patent rights of brand-name drug makers — a crucial incentive for research on new drugs. It is also said that it would take several years after any new bill is passed for the FDA to issue regulations. Then, because of safety concerns, the agency could als......o other non-pathogenic families of Borrelia. The patent covers the development of the chimeric proteins themselves, the nucleic acids (genetic material) used to generate the proteins, the methods used to make the proteins, the methods used to deliver either the proteins or nucleic acids, the use of the pr......t of India is moving fast to plug all loopholes in patent law// implementation. It has now been notified that all patent litigations filed in various courts in the country after notification of the amended Patent Act have...